Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: Cross-sectional data and a systematic review of resistance studies

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Brown, Tyler ^a,b   Smith, Linda S ^b   Oo, Eh Kalu Shwe ^c   Shawng, Kum ^d   Lee, Thomas J ^b,f   Sullivan, David ^e   Beyrer, Chris ^e   Richards, Adam K ^b,g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Global Health Access Program   (United States)

^c Tak   (Thailand)

^d Kachin Baptist Convention ^*  (Myanmar)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Artemisinin resistance; Conflict; Genetic; Malaria; Myanmar; Plasmodium falciparum; Subclinical infection

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN; RNA 18S;

ADOLESCENT; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BLOOD SAMPLING; CHILD; COMMUNITY CARE; COPY NUMBER VARIATION; DISEASE SURVEILLANCE; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENOTYPING TECHNIQUE; HEALTH CARE PERSONNEL; HUMAN; INFECTION RISK; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MASS SCREENING; MYANMAR; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ASYMPTOMATIC DISEASES; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MYANMAR; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; YOUNG ADULT;

EID: 84866280812     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-333     Document Type: Article

References (82)

1. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, Lancet 2012 379 1960 1966 10.1016/S0140-6736(12)60484-X 22484134
2. A major genome region underlying artemisinin resistance in malaria. Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJ, Science 2012 336 79 82 10.1126/science.1215966 22491853
3. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AJ, Johnson A, Hien TT, McGready R, Farrar JJ, Looareesuwan S, Day NP, Green MD, White NJ, Trop Med Int Health 2004 9 1241 1246 10.1111/j.1365-3156.2004.01342.x 15598255
4. Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt. Takahashi N, Tanabe K, Tsukahara T, Dzodzomenyo M, Dysoley L, Khamlome B, Sattabongkot J, Nakamura M, Sakurai M, Kobayashi J, Kaneko A, Endo H, Hombhanje F, Tsuboi T, Mita T, Malar J 2012 11 92 10.1186/1475-2875-11-92 22453078
5. Global malaria mortality between 1980 and 2010: a systematic analysis. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD, Lancet 2012 379 413 431 10.1016/S0140-6736(12) 60034-8 22305225
6. Averting a malaria disaster. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P, Lancet 1999 353 1965 1967 10.1016/S0140-6736(98)07367-X 10371589
7. WHO and Department of Health, Myanmar, Strategic Framework for Artemisinin Resistance Containment in Myanmar (MARC) 2011-2015 Myanmar: Department of Health, Myanmar and World Health Organization 2011
8. WHO, Global report on antimalarial drug efficacy and drug resistance: 2000-2010 Geneva: World Health Organization 2010
9. Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand. Muhamad P, Phompradit P, Sornjai W, Maensathian T, Chaijaroenkul W, Rueangweerayut R, Na-Bangchang K, Am J Trop Med Hyg 2011 85 568 572 10.4269/ajtmh.2011.11-0194 21896824
10. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, Nash D, Singhasivanon P, Anderson TJ, Krishna S, White NJ, Nosten F, Clin Infect Dis 2006 42 1570 1577 10.1086/503423 16652314
11. Probability of emergence of antimalarial resistance in different stages of the parasite life cycle. Pongtavornpinyo W, Hastings IM, Dondorp A, White LJ, Maude RJ, Saralamba S, Day NP, White NJ, Boni MF, Evol App 2009 2 52 61 10.1111/j.1752-4571.2008.00067.x
12. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick SR, Antimicrob Agents Chemother 2003 47 2418 2423 10.1128/AAC.47.8.2418-2423.2003 12878499
13. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742
14. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P, Malar J 2009 8 89 10.1186/1475-2875-8-89 19413906
15. Antimalarial multi-drug resistance in Asia: mechanisms and assessment. Uhlemann AC, Krishna S, Curr Top Microbiol Immunol 2005 295 39 53 10.1007/3-540-29088-5-2 16265886
16. Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. Djimde AA, Dolo A, Ouattara A, Diakite S, Plowe CV, Doumbo OK, J Infect Dis 2004 190 853 855 10.1086/422758 15272415
17. Cross-border malaria control for internally displaced persons: observational results from a pilot programme in eastern Burma/Myanmar. Richards AK, Banek K, Mullany LC, Lee CI, Smith L, Oo EK, Lee TJ, Trop Med Int Health 2009 14 512 521 10.1111/j.1365-3156.2009.02258.x 19254232
18. Internally displaced human resources for health: villager health worker partnerships to scale up a malaria control programme in active conflict areas of eastern Burma. Lee CI, Smith LS, Shwe Oo EK, Scharschmidt BC, Whichard E, Kler T, Lee TJ, Richards AK, Glob Public Health 2009 4 229 241 10.1080/ 17441690802676360 19384681
19. Prevalence of Plasmodium falciparum in active conflict areas of eastern Burma: a summary of cross-sectional data. Richards AK, Smith L, Mullany LC, Lee CI, Whichard E, Banek K, Mahn M, Shwe Oo EK, Lee TJ, Confl Health 2007 1 9 10.1186/1752-1505-1-9 17803819
20. Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia. Shah NK, Alker AP, Sem R, Susanti AI, Muth S, Maguire JD, Duong S, Ariey F, Meshnick SR, Wongsrichanalai C, Emerg Infect Dis 2008 14 1637 1640 10.3201/eid1410.080080 18826834
21. Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. da Silva-Nunes M, Moreno M, Conn JE, Gamboa D, Abeles S, Vinetz JM, Ferreira MU, Acta Trop 2012 121 281 291 10.1016/j.actatropica.2011.10.001 22015425
22. Large-scale malaria survey in Cambodia: Novel insights on species distribution and risk factors. Incardona S, Vong S, Chiv L, Lim P, Nhem S, Sem R, Khim N, Doung S, Mercerau-Puijalon O, Fandeur T, Malar J 2007 6 37 10.1186/1475-2875-6-37 17389041
23. Aggressive active case detection: a malaria control strategy based on the Brazilian model. Macauley C, Soc Sci Med 2005 60 563 573 10.1016/j.socscimed. 2004.05.025 15550304
24. Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar. Soe S, Khin Saw A, Htay A, Nay W, Tin A, Than S, Roussilhon C, Perignon JL, Druilhe P, Trans R Soc Trop Med Hyg 2001 95 81 84 10.1016/S0035-9203(01)90342-6 11280074
25. Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. Alves FP, Gil LH, Marrelli MT, Ribolla PE, Camargo EP, Da Silva LH, J Med Entomol 2005 42 777 779 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2 16363160
26. Considerations on the use of nucleic acid-based amplification for malaria parasite detection. Proux S, Suwanarusk R, Barends M, Zwang J, Price RN, Leimanis M, Kiricharoen L, Laochan N, Russell B, Nosten F, Snounou G, Malar J 2011 10 323 10.1186/1475-2875-10-323 22034851
27. Plasmodium falciparum pfmdr1 amplification, mefloquine resistance, and parasite fitness. Preechapornkul P, Imwong M, Chotivanich K, Pongtavornpinyo W, Dondorp AM, Day NP, White NJ, Pukrittayakamee S, Antimicrob Agents Chemother 2009 53 1509 1515 10.1128/AAC.00241-08 19164150
28. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies. Babiker HA, Hastings IM, Swedberg G, Expert Rev Anti Infect Ther 2009 7 581 593 10.1586/eri.09.29 19485798
29. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Barnes KI, White NJ, Acta Trop 2005 94 230 240 10.1016/j.actatropica.2005.04.014 15878154
30. Effects of artemisinin derivatives on malaria transmissibility. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, Lancet 1996 347 1654 1658 10.1016/S0140-6736(96)91488-9 8642959
31. Health and human rights in Chin State Western Burma: a population-based assessment using multistaged household cluster sampling. Sollom R, Richards AK, Parmar P, Mullany LC, Lian SB, Iacopino V, Beyrer C, PLoS Med 2011 8 1001007 10.1371/journal.pmed.1001007 21346799
32. Population-based survey methods to quantify associations between human rights violations and health outcomes among internally displaced persons in eastern Burma. Mullany LC, Richards AK, Lee CI, Suwanvanichkij V, Maung C, Mahn M, Beyrer C, Lee TJ, J Epidemiol Community Health 2007 61 908 914 10.1136/jech.2006.055087 17873229
33. Prevalence and density-related concordance of three diagnostic tests for malaria in a region of Tanzania with hypoendemic malaria. Schachterle SE, Mtove G, Levens JP, Clemens EG, Shi L, Raj A, Munoz B, Reller ME, West S, Dumler JS, Sullivan D, J Clin Microbiol 2011 49 3885 3891 10.1128/JCM.01157-11 21880972
34. Comparison of diagnostic methods for the detection and quantification of the four sympatric Plasmodium species in field samples from Papua New Guinea. Rosanas-Urgell A, Mueller D, Betuela I, Barnadas C, Iga J, Zimmerman PA, del Portillo HA, Siba P, Mueller I, Felger I, Malar J 2010 9 361 10.1186/1475-2875-9-361 21156052
35. A novel real-time PCR assay for the detection of Plasmodium falciparum and Plasmodium vivax malaria in low parasitized individuals. Hwang SY, Kim SH, Lee GY, Hang VT, Moon CS, Shin JH, Koo WL, Kim SY, Park HJ, Park HO, Kho WG, Acta Trop 2011 120 40 45 10.1016/j.actatropica.2011.05.006 21664340
36. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Alker AP, Lim P, Sem R, Shah NK, Yi P, Bouth DM, Tsuyuoka R, Maguire JD, Fandeur T, Ariey F, Wongsrichanalai C, Meshnick SR, Am J Trop Med Hyg 2007 76 641 647 17426163
37. Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. Sutherland CJ, Haustein T, Gadalla N, Armstrong M, Doherty JF, Chiodini PL, J Antimicrob Chemother 2007 59 1197 1199 10.1093/jac/dkm104 17475629
38. Thai Burma Border Consortium, Displaced villages in Eastern Burma. 2008-2011
39. Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum. Poyomtip T, Suwandittakul N, Sitthichot N, Khositnithikul R, Tan-ariya P, Mungthin M, Malar J 2012 11 7 10.1186/1475-2875-11-7 22221394
40. Multidrug-resistant genotypes of Plasmodium falciparum, Myanmar. Yang Z, Li C, Miao M, Zhang Z, Sun X, Meng H, Emerg Inf Dis 2011 17 498 501 10.3201/eid1703.100870
41. in vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H + exchanger. Meng H, Zhang R, Yang H, Fan Q, Su X, Miao J, Cui L, Yang Z, Antimicrob Agents Chemother 2010 54 4306 4313 10.1128/AAC.00321-10 20643902
42. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province, China. Yang Z, Zhang Z, Sun X, Wan W, Cui L, Zhang X, Zhong D, Yan G, Cui L, Trop Med Int Health 2007 12 1051 1060 10.1111/j.1365-3156.2007. 01882.x 17875016
43. Spatio-temporal distribution of Plasmodium falciparum and P. vivax malaria in Thailand. Zhou G, Sirichaisinthop J, Sattabongkot J, Jones J, Bjornstad ON, Yan G, Cui L, Am J Trop Med Hyg 2005 72 256 262 15772317
44. High prevalence of malaria in Myanmar migrant workers in a rural district near the Thailand-Myanmar border. Wiwanitkit V, Scand J Infect Dis 2002 34 236 237 10.1080/00365540110077272 12030408
45. Deployment of early diagnosis and mefloquine- artesunate treatment of falciparum malaria in Thailand: The Tak malaria initiative. Carrara VI, Sirilak S, Thonglairuam J, Rojanawatsirivet C, Proux S, Gilbos V, Brockman A, Ashley EA, McGready R, Krudsood S, Leemingsawat S, Looareesuwan S, Singhasivanon P, White N, Nosten F, PLoS Med 2006 3 183 10.1371/journal.pmed.0030183 16719547
46. [Malaria situation in the People's Republic of China in 2006] (in Chinese). Zhou SS, Wang Y, Tang LH, Chinese journal of parasitology & parasitic diseases 2007 25 439 441 23116060
47. Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand. Uhlemann AC, McGready R, Ashley EA, Brockman A, Singhasivanon P, Krishna S, White NJ, Nosten F, Price RN, J Infect Dis 2007 195 134 141 10.1086/509809 17152017
48. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Coulibaly D, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
49. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV, J Infect Dis 2003 187 1870 1875 10.1086/375419 12792863
50. Return of chloroquine antimalarial efficacy in Malawi. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV, N Engl J Med 2006 355 1959 1966 10.1056/NEJMoa062032 17093247
51. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ, Malar J 2007 6 121 10.1186/1475-2875-6-121 17822535
52. Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial. Phyo AP, Lwin KM, Price RN, Ashley EA, Russell B, Sriprawat K, Lindegardh N, Singhasivanon P, White NJ, Nosten F, Clin Infect Dis 2011 53 977 984 10.1093/cid/cir631 22002979
53. Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand. Rijken MJ, Boel ME, Russell B, Imwong M, Leimanis ML, Phyo AP, Muehlenbachs A, Lindegardh N, McGready R, Renia L, Snounou G, Singhasivanon P, Nosten F, Malar J 2011 10 113 10.1186/1475-2875-10-113 21545737
54. Molecular epidemiology of drug-resistant malaria in western Kenya highlands. Zhong D, Afrane Y, Githeko A, Cui L, Menge DM, Yan G, BMC Infect Dis 2008 8 105 10.1186/1471-2334-8-105 18671871
55. Deamplification of pfmdr1-containing amplicon on chromosome 5 in Plasmodium falciparum is associated with reduced resistance to artelinic acid in vitro. Chen N, Chavchich M, Peters JM, Kyle DE, Gatton ML, Cheng Q, Antimicrob Agents Chemother 2010 54 3395 3401 10.1128/AAC.01421-09 20421397
56. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar. Kang JM, Moon SU, Kim JY, Cho SH, Lin K, Sohn WM, Kim TS, Na BK, Malar J 2010 9 131 10.1186/1475-2875-9-131 20478015
57. Where there is no health research: what can be done to fill the global gaps in health research? McKee M, Stuckler D, Basu S, PLoS Med 2012 9 1001209 10.1371/journal.pmed.1001209 22545025
58. Conflict and emerging infectious diseases. Gayer M, Legros D, Formenty P, Connolly MA, Emerg Infect Dis 2007 13 1625 1631 10.3201/eid1311.061093 18217543
59. Civil Conflict and Health Information: The Democratic Republic of Congo. Beyrer C, Terzian A, Lowther S, Zambrano JA, Galai N, Melchior MK, Public Health and Human Rights: Evidence-based Approaches Baltimore: Johns Hopkins University Press, Chris B, Pizer HF, 2007 268 285
60. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Smithuis F, Kyaw MK, Phe O, Aye KZ, Htet L, Barends M, Lindegardh N, Singtoroj T, Ashley E, Lwin S, et al. Lancet 2006 367 2075 2085 10.1016/S0140-6736(06)68931-9 16798391
61. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Stepniewska K, White NJ, Lancet Infect Dis 2010 10 673 681 10.1016/S1473-3099(10)70187-0 20832366
62. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar. Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ, Trop Med Int Health 2004 9 1184 1190 10.1111/j.1365-3156.2004.01323.x 15548314
63. Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens. Smithuis F, van der Broek I, Katterman N, Kyaw MK, Brockman A, Lwin S, White NJ, Trans R Soc Trop Med Hyg 2004 98 182 192 10.1016/S0035-9203(03)00035-X 15024929
64. in vitro susceptibility of Plasmodium falciparum isolates from Myanmar to antimalarial drugs. Wongsrichanalai C, Lin K, Pang LW, Faiz MA, Noedl H, Wimonwattrawatee T, Laoboonchai A, Kawamoto F, Am J Trop Med Hyg 2001 65 450 455 11716097
65. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F, PLoS One 2009 4 4551 10.1371/journal.pone.0004551 19234601
66. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ, Lancet 1991 337 1140 1143 10.1016/0140- 6736(91)92798-7 1674024
67. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185
68. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K, Acta Trop 2010 113 190 194 10.1016/j.actatropica.2009.10.016 19879850
69. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, Das D, Phyo AP, Lwin KM, Pukrittayakamee S, Lee SJ, Saisung S, Koecharoen K, Nguon C, Day NP, Socheat D, White NJ, Antimicrob Agents Chemother 2010 54 2886 2892 10.1128/AAC.00032-10 20421395
70. Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border. Phompradit P, Wisedpanichkij R, Muhamad P, Chaijaroenkul W, Na-Bangchang K, Acta Trop 2011 120 130 135 10.1016/j.actatropica.2011.07.003 21777558
71. Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand. Congpuong K, Na Bangchang K, Mungthin M, Bualombai P, Wernsdorfer WH, Trop Med Int Health 2005 10 717 722 10.1111/j.1365-3156.2005.01450.x 16045457
72. Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. Yang H, Liu D, Yang Y, Fan B, Yang P, Li X, Li C, Dong Y, Yang C, Trans R Soc Trop Med Hyg 2003 97 226 228 10.1016/S0035-9203(03) 90127-1 14584382
73. Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981-2006. Yang H, Yang Y, Yang P, Li X, Gao B, Zhang Z, Yang Z, Cui L, Acta Trop 2008 108 44 49 10.1016/j.actatropica.2008.08.010 18822265
74. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China. Zhang GQ, Guan YY, Zheng B, Wu S, Tang LH, Trop Med Int Health 2009 14 1266 1271 10.1111/j.1365-3156.2009.02342.x 19772548
75. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Shah NK, Dhillon GP, Dash AP, Arora U, Meshnick SR, Valecha N, Lancet Infect Dis 2011 11 57 64 10.1016/S1473-3099(10)70214-0 21183147
76. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India. Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, Sharma YD, Malar J 2009 8 107 10.1186/1475-2875-8-107 19454000
77. Therapeutic efficacy of anti-malarials in Plasmodium falciparum malaria in an Indo-Myanmar border area of Arunachal Pradesh. Mohapatra PK, Namchoom NS, Prakash A, Bhattacharya DR, Goswami BK, Mahanta J, Indian J Med Res 2003 118 71 76 14680202
78. Population genetic analyses of Plasmodium falciparum chloroquine receptor transporter gene haplotypes reveal the evolutionary history of chloroquine-resistant malaria in India. Awasthi G, Prasad GB, Das A, Int J Parasitol 2011 41 705 709 10.1016/j.ijpara.2011.03.002 21447338
79. Efficacy of chloroquine + sulfadoxine-pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. van den Broek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M, Rahman MR, Bangali AM, Das S, Barends M, Faiz AM, Trans R Soc Trop Med Hyg 2005 99 727 735 10.1016/j.trstmh.2005.02.007 16095643
80. Artemisinin-resistant malaria in Asia. Noedl H, Socheat D, Satimai W, N Engl J Med 2009 361 540 541 10.1056/NEJMc0900231 19641219
81. Drug-resistant malaria in Bangladesh: an in vitro assessment. Noedl H, Faiz MA, Yunus EB, Rahman MR, Hossain MA, Samad R, Miller RS, Pang LW, Wongsrichanalai C, Am J Trop Med Hyg 2003 68 140 142 12641401
82. Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh. van den Broek IV, van der Wardt S, Talukder L, Chakma S, Brockman A, Nair S, Anderson TC, Trop Med Int Health 2004 9 680 687 10.1111/j.1365-3156. 2004.01249.x 15189458